Your browser doesn't support javascript.
loading
Efficacy and Safety of RET-Specific Kinase Inhibitors in RET-Altered Cancers: A Systematic Review.
Ali, Muhammad Ashar; Shah, Syed S; Ali, Rimsha; Bajwa, Shammas Farooq; Rehman, Sana; Anwar, Aqsa; Anwar, Muhammad Yasir; Saeed, Memoona; Mirza, Nayab; Aiman, Wajeeha.
Affiliation
  • Ali MA; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Shah SS; Department of Medicine, University of Kentucky, Lexington, Kentucky, USA.
  • Ali R; Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
  • Bajwa SF; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
  • Rehman S; Department of Medicine, Shaikh Khalifa Bin Zayed Al Nahyan Medical and Dental College, Lahore, Pakistan.
  • Anwar A; Department of Medicine, Ameer-ud Din Medical College, Lahore, Pakistan.
  • Anwar MY; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
  • Saeed M; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
  • Mirza N; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
  • Aiman W; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Cancer Invest ; 41(8): 739-749, 2023 Sep.
Article de En | MEDLINE | ID: mdl-37782113
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Effets secondaires indésirables des médicaments / Hypertension artérielle / Tumeurs du poumon / Tumeurs / Neutropénie Type d'étude: Systematic_reviews Limites: Humans Langue: En Journal: Cancer Invest Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Effets secondaires indésirables des médicaments / Hypertension artérielle / Tumeurs du poumon / Tumeurs / Neutropénie Type d'étude: Systematic_reviews Limites: Humans Langue: En Journal: Cancer Invest Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni